Cooper Companies | COO - Cost Of Sales

Stock Price
83.63
Daily Change
-0.38 -0.45%
Monthly
3.91%
Yearly
-7.47%
Q1 Forecast
81.46

Cooper Companies reported $464.2M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Abbott USD 4.92B 535M Dec/2025
Align Technology USD 363.97M 7.48M Dec/2025
AtriCure USD 35.16M 2.23M Dec/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Bausch Health Companies USD 1.03B 284M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Boston Scientific USD 1.84B 82M Dec/2025
Cooper Companies USD 464.2M 45.9M Sep/2025
Dentsply International USD 518M 55M Dec/2025
Dexcom USD 466.9M 11M Dec/2025
Edwards Lifesciences USD 343M 2.2M Dec/2025
Globus Medical USD 282.38M 3.42M Sep/2025
Haemonetics USD 136.58M 4.01M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Inogen USD 39.59M 1.27M Sep/2024
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
Intuitive Surgical USD 961.9M 119.2M Dec/2025
J&J USD 7.97B 689M Dec/2025
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Novartis USD 3.54B 216M Sep/2025
ResMed USD 555.85M 29.13M Dec/2025
STAAR Surgical USD 16.86M 5.34M Sep/2025
Steris USD 840.7M 26.3M Dec/2025
Stryker USD 2.69B 373M Dec/2025
Tandem Diabetes Care USD 122.92M 7.96M Dec/2025
Teleflex USD 261.54M 199.84M Dec/2025
Utah Medical Products USD 4.2M 50K Sep/2024
Zimmer Biomet Holdings USD 970.1M 234.3M Dec/2025